Cobenfy is the first antipsychotic drug to treat schizophrenia by targeting cholinergic receptors instead of dopamine receptors Cobenfy is the first antipsychotic drug to treat schizophrenia by targeting cholinergic receptors instead of dopamine receptors Science Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu
FDA approval for Cobenfy casts light on schizophrenia’s wickedness
